News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs
deptmedicine.arizona.edu/news/2023/dr-rachna-shroff-selected-lead-hematology-and-oncology-division
Dec 16, 2024, 08:37

Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared an article by Rachna T. Shroff et al. on X, adding the following:

“Open Access in JCO ASCO

SWOG S1815 found no OS or PFS benefit for adding nab-paclitaxel to gemcitabine-cisplatin (GAP vs GC) in advanced biliary tract cancers (BTCs). Median OS: 14.0 vs 13.6 months (P=0.41). GAP showed more toxicity.”

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Authors: Rachna T. Shroff, Gentry King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind M. Javle, Imane El Dika, Benjamin Tan, Puneet Cheema, Anuj Patel, Renuka Iyer, R. Katie Kelley, Jaykumar Thumar, Anthony El-Khoueiry, Katherine A. Guthrie, E. Gabriela Chiorean, Howard Hochster, Philip A. Philip

Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs

advanced biliary cancer Ben Westphalen Biliary tract cancers BTC research cancer cancer trials GAP vs GC gemcitabine-cisplatin JCO ASCO nab-paclitaxel OncoDaily Oncology overall survival progression-free survival SWOG S1815
Special Coverage
Dialogues
Jan 15, 2025, 21:45
Next-Generation Sequencing and Targets in Early-Phase Colorectal Cancer Drug Development
Insight
Jan 15, 2025, 18:32
MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening
Insight
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Blog
Jan 15, 2025, 18:25
Discussion on advancing the Global Cancer Fund at The White House - ASCO
Blog
Jan 15, 2025, 18:19
Antonio Passaro: COCOON study meets primary endpoint
Blog
Jan 15, 2025, 17:58
Felice Gorordo: The White House's round table on the creation of the Global Cancer Fund
Insight
Jan 15, 2025, 17:48
ESO announced the mentorship pairings for 2025
Insight
Jan 15, 2025, 17:38
Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI
Blog
Jan 15, 2025, 17:37
Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine
Blog
Jan 15, 2025, 17:33
Exploring the Future of HR+/HER2- MBC Treatment – Live Webinar by SPCC
Insight
Jan 15, 2025, 17:27
Integration of Generative AI into Radiation Therapy practice
Insight
Jan 15, 2025, 17:26
Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas